Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Cash & Current Investments readings, the most recent being $48.4 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 36.09% to $48.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.4 million, a 36.09% decrease, with the full-year FY2025 number at $48.4 million, down 36.09% from a year prior.
  • Cash & Current Investments hit $48.4 million in Q4 2025 for Treace Medical Concepts, down from $57.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $170.7 million in Q1 2023 to a low of $16.2 million in Q1 2021.
  • Median Cash & Current Investments over the past 5 years was $98.5 million (2022), compared with a mean of $94.9 million.
  • Biggest five-year swings in Cash & Current Investments: surged 1060.81% in 2021 and later plummeted 38.57% in 2024.
  • Treace Medical Concepts' Cash & Current Investments stood at $105.8 million in 2021, then fell by 23.23% to $81.3 million in 2022, then soared by 51.62% to $123.2 million in 2023, then plummeted by 38.57% to $75.7 million in 2024, then tumbled by 36.09% to $48.4 million in 2025.
  • The last three reported values for Cash & Current Investments were $48.4 million (Q4 2025), $57.4 million (Q3 2025), and $69.3 million (Q2 2025) per Business Quant data.